Regeneron Pharmaceuticals - 34 Year Stock Price History | REGN

Historical daily share price chart and data for Regeneron Pharmaceuticals since 1991 adjusted for splits and dividends. The latest closing stock price for Regeneron Pharmaceuticals as of June 13, 2025 is 529.24.
  • The all-time high Regeneron Pharmaceuticals stock closing price was 1198.45 on August 27, 2024.
  • The Regeneron Pharmaceuticals 52-week high stock price is 1211.20, which is 128.9% above the current share price.
  • The Regeneron Pharmaceuticals 52-week low stock price is 476.49, which is 10% below the current share price.
  • The average Regeneron Pharmaceuticals stock price for the last 52 weeks is 823.77.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Regeneron Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 630.1693 713.2180 743.7310 483.0700 529.2400 -25.50%
2024 965.6237 902.5050 1198.4500 699.9150 710.3660 -18.90%
2023 781.6642 718.4840 879.2690 678.6140 875.8690 21.73%
2022 660.6900 625.3710 764.2770 546.8380 719.5010 14.25%
2021 556.7856 481.5290 679.0830 445.4990 629.7790 30.72%
2020 530.8904 372.3210 656.3960 335.2530 481.7780 28.66%
2019 342.5594 371.4130 438.3580 272.7060 374.4450 0.53%
2018 350.6986 381.5450 407.3840 283.8150 372.4700 -0.65%
2017 421.3183 378.6530 525.0780 339.8110 374.9240 2.42%
2016 393.4125 515.1260 518.0480 330.1370 366.0780 -32.38%
2015 497.3582 409.0290 590.7670 395.7960 541.3730 32.33%
2014 332.7478 273.8330 433.7510 266.8820 409.1190 49.05%
2013 239.2000 180.7010 315.7570 157.9830 274.4810 60.89%
2012 130.4733 56.2744 187.2230 56.2744 170.5980 208.62%
2011 50.9658 33.7268 71.9910 32.5201 55.2772 68.84%
2010 26.1406 24.5621 33.5971 20.7327 32.7395 35.77%
2009 17.6683 18.6484 24.6718 12.0168 24.1133 31.70%
2008 18.9271 23.4951 24.7017 13.3132 18.3094 -23.98%
2007 20.4928 19.7554 28.5212 13.6223 24.0834 20.33%
2006 16.0708 15.8562 24.2131 11.0893 20.0147 26.23%
2005 8.2753 9.0151 16.7836 4.6172 15.8562 72.64%
2004 10.8053 15.0085 16.6739 6.8311 9.1846 -37.39%
2003 14.7150 19.0374 22.2485 5.8638 14.6694 -20.53%
2002 18.8325 27.8430 29.2292 11.3287 18.4590 -34.27%
2001 28.2992 35.4645 38.8925 20.5432 28.0824 -20.15%
2000 27.2595 12.2786 56.3442 11.4683 35.1684 176.59%
1999 7.7957 7.9156 12.7149 5.5472 12.7149 72.88%
1998 8.1252 8.8505 10.9073 5.8588 7.3547 -13.87%
1997 9.8584 17.0778 19.3216 6.4821 8.5389 -46.90%
1996 16.2180 13.2135 24.5571 11.8423 16.0805 26.47%
1995 9.5748 3.3034 16.4545 3.3034 12.7149 325.01%
1994 7.0163 15.2080 17.2024 2.9917 2.9917 -80.65%
1993 15.4592 11.9669 21.4407 10.9697 15.4573 29.17%
1992 12.9828 18.6983 22.4380 7.9779 11.9669 -33.79%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $56.341B $14.202B
Regeneron is a biotechnology company focused on the discovery, development and commercialization of treatments targeting serious medical conditions. The company's portfolio boasts nine marketed drugs - Eylea, Dupixent, Praluent, Kevzara, Libtayo, Evkeeza, Inmazeb Arcalyst and Zaltrap. The company also developed an antibody cocktail for COVID-19, REGEN-COV. REGEN-COV is a cocktail of two monoclonal antibodies and was designed specifically to block the infectivity of SARS-CoV-2, the virus that causes COVID-19. Regeneron has a collaboration agreement with Roche for the same. While Regeneron has co-developed Eylea with Bayer's HealthCare unit, Praluent was co-developed with Sanofi. Regeneron collaborated with Bayer for the joint development and commercialization of co-formulated combinations of Eylea, rinucumab and nesvacumab for the treatment of ocular diseases or disorders outside the United States.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $232.596B 17.36
Amgen (AMGN) United States $159.855B 14.32
Gilead Sciences (GILD) United States $139.382B 14.48
Vertex Pharmaceuticals (VRTX) United States $118.142B 0.00
Bristol Myers Squibb (BMY) United States $103.158B 6.91
GSK (GSK) United Kingdom $87.087B 10.41
CSL (CSLLY) Australia $76.641B 0.00
Alnylam Pharmaceuticals (ALNY) United States $39.725B 0.00
Argenex SE (ARGX) Netherlands $35.827B 97.79
BioNTech SE (BNTX) Germany $25.222B 0.00
Royalty Pharma (RPRX) United States $19.830B 8.38
Biogen (BIIB) United States $19.387B 8.36
Insmed (INSM) United States $17.646B 0.00
Genmab (GNMSF) Denmark $14.821B 15.15
Genmab (GMAB) Denmark $14.806B 16.61
Illumina (ILMN) United States $13.951B 26.47
Incyte (INCY) United States $13.399B 101.79
Exelixis (EXEL) United States $11.394B 19.34
Swedish Orphan Biovitrum (BIOVF) Sweden $11.389B 29.08
BioMarin Pharmaceutical (BMRN) United States $10.985B 17.84
Moderna (MRNA) United States $10.577B 0.00
QIAGEN (QGEN) Netherlands $10.534B 20.50
Ascendis Pharma (ASND) Denmark $10.442B 0.00
Exact Sciences (EXAS) United States $10.188B 0.00
Blueprint Medicines (BPMC) United States $8.280B 0.00
Bio-Techne Corp (TECH) United States $8.078B 30.14
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $7.944B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $7.874B 0.00
Roivant Sciences (ROIV) United Kingdom $7.797B 0.00
Revolution Medicines (RVMD) United States $7.657B 0.00
Repligen (RGEN) United States $7.377B 82.58
Legend Biotech (LEGN) United States $6.966B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Halozyme Therapeutics (HALO) United States $6.720B 12.86
Jazz Pharmaceuticals (JAZZ) Ireland $6.674B 6.55
Guardant Health (GH) United States $6.073B 0.00
TG Therapeutics (TGTX) United States $5.933B 155.71
Telix Pharmaceuticals (TLX) Australia $5.903B 0.00
Nuvalent (NUVL) United States $5.595B 0.00
Zealand Pharma (ZLDPF) Denmark $5.265B 0.00
Axsome Therapeutics (AXSM) United States $5.231B 0.00
ADMA Biologics Inc (ADMA) United States $5.157B 38.57
Alkermes (ALKS) Ireland $5.076B 13.62
Zai Lab (ZLAB) China $4.747B 0.00
Vaxcyte (PCVX) United States $4.445B 0.00
Akero Therapeutics (AKRO) United States $4.270B 0.00
Krystal Biotech (KRYS) United States $4.055B 31.25
PTC Therapeutics (PTCT) United States $4.041B 7.03
Rhythm Pharmaceuticals (RYTM) United States $4.009B 0.00
Cytokinetics (CYTK) United States $3.965B 0.00
Avidity Biosciences (RNA) United States $3.874B 0.00
Merus (MRUS) Netherlands $3.834B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.715B 0.00
Sarepta Therapeutics (SRPT) United States $3.667B 0.00
Arcellx (ACLX) United States $3.665B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.638B 31.97
Metsera (MTSR) United States $3.633B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.565B 0.00
SpringWorks Therapeutics (SWTX) United States $3.523B 0.00
Protagonist Therapeutics (PTGX) United States $3.491B 75.09
Viking Therapeutics (VKTX) United States $3.210B 0.00
Scholar Rock Holding (SRRK) United States $3.164B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.089B 0.00
Kymera Therapeutics (KYMR) United States $3.080B 0.00
Alvotech (ALVO) Luxembourg $2.967B 16.97
MoonLake Immunotherapeutics (MLTX) Switzerland $2.818B 0.00
ImmunityBio (IBRX) United States $2.816B 0.00
Ascentage Pharma Group - (AAPG) China $2.789B 0.00
Immunovant (IMVT) United States $2.725B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.517B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.428B 0.00
Apellis Pharmaceuticals (APLS) United States $2.421B 0.00
Bavarian Nordic (BVNRY) Denmark $2.245B 11.86
Arrowhead Pharmaceuticals (ARWR) United States $2.240B 0.00
Ligand Pharmaceuticals (LGND) United States $2.208B 0.00
Denali Therapeutics (DNLI) United States $2.168B 0.00
Vericel (VCEL) United States $2.139B 1416.00
NovoCure (NVCR) Jersey $2.029B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.023B 0.00
CG Oncology (CGON) United States $2.020B 0.00
Twist Bioscience (TWST) United States $2.015B 0.00
Agios Pharmaceuticals (AGIO) United States $1.998B 0.00
Belite Bio (BLTE) United States $1.978B 0.00
IDEAYA Biosciences (IDYA) United States $1.951B 0.00
Apogee Therapeutics (APGE) United States $1.928B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.914B 12.72
Amicus Therapeutics (FOLD) United States $1.900B 205.67
Disc Medicine (IRON) United States $1.826B 0.00
Certara (CERT) United States $1.814B 33.88
Immunocore Holdings (IMCR) United Kingdom $1.790B 0.00
Beam Therapeutics (BEAM) United States $1.754B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.720B 0.00
Edgewise Therapeutics (EWTX) United States $1.622B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.609B 0.00
Biohaven (BHVN) United States $1.592B 0.00
Adaptive Biotechnologies (ADPT) United States $1.581B 0.00
Mesoblast (MESO) Australia $1.554B 0.00
BGM Group (BGM) China $1.518B 0.00
Janux Therapeutics (JANX) United States $1.513B 0.00
GRAIL (GRAL) United States $1.508B 0.00
Vera Therapeutics (VERA) United States $1.436B 0.00
89BIO (ETNB) United States $1.404B 0.00
Celldex Therapeutics (CLDX) United States $1.351B 0.00
ANI Pharmaceuticals (ANIP) United States $1.346B 13.87
Travere Therapeutics (TVTX) United States $1.327B 0.00
Viridian Therapeutics (VRDN) United States $1.279B 0.00
Structure Therapeutics (GPCR) United States $1.274B 0.00
Anbio Biotechnology (NNNN) Germany $1.266B 0.00
CureVac (CVAC) Germany $1.256B 6.09
Dynavax Technologies (DVAX) United States $1.249B 74.29
Liquidia Technologies (LQDA) United States $1.235B 0.00
MannKind (MNKD) United States $1.164B 23.94
Novavax (NVAX) United States $1.158B 2.70
Pacira BioSciences (PCRX) United States $1.132B 10.77
Niagen Bioscience (NAGE) United States $1.114B 157.11
WAVE Life Sciences (WVE) Singapore $1.110B 0.00
Spyre Therapeutics (SYRE) United States $1.067B 0.00
CorMedix Inc (CRMD) United States $1.008B 67.54
Geron (GERN) United States $0.994B 0.00
Arcus Biosciences (RCUS) United States $0.990B 0.00
Mineralys Therapeutics (MLYS) United States $0.972B 0.00
NeoGenomics (NEO) United States $0.951B 0.00
AbCellera Biologics (ABCL) Canada $0.940B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.918B 0.00
Praxis Precision Medicines (PRAX) United States $0.917B 0.00
Nurix Therapeutics (NRIX) United States $0.912B 0.00
Zymeworks (ZYME) United States $0.911B 0.00
MiMedx (MDXG) United States $0.904B 21.86
Pharvaris (PHVS) Netherlands $0.901B 0.00
UniQure (QURE) Netherlands $0.876B 0.00
Intellia Therapeutics (NTLA) United States $0.865B 0.00
Oculis Holding AG (OCS) Switzerland $0.859B 0.00
Immunome (IMNM) United States $0.852B 0.00
LENZ Therapeutics (LENZ) United States $0.833B 0.00
Oric Pharmaceuticals (ORIC) United States $0.824B 0.00
Cogent Biosciences (COGT) United States $0.822B 0.00
ArriVent BioPharma (AVBP) United States $0.808B 0.00
Pharming Group (PHGUF) Netherlands $0.795B 0.00
Pharming Group (PHAR) Netherlands $0.787B 0.00
Iovance Biotherapeutics (IOVA) United States $0.771B 0.00
Replimune (REPL) United States $0.762B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.760B 0.00
Gyre Therapeutics (GYRE) United States $0.757B 201.75
Sionna Therapeutics (SION) United States $0.750B 0.00
Immatics (IMTX) Germany $0.746B 0.00
Trevi Therapeutics (TRVI) United States $0.724B 0.00
Vir Biotechnology (VIR) United States $0.722B 0.00
Anavex Life Sciences (AVXL) United States $0.702B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.700B 0.00
AnaptysBio (ANAB) United States $0.688B 0.00
Arbutus Biopharma (ABUS) United States $0.686B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.678B 0.00
GH Research (GHRS) Ireland $0.668B 0.00
Stoke Therapeutics (STOK) United States $0.645B 14.96
Sinovac Biotech (SVA) China $0.645B 0.00
Bicara Therapeutics (BCAX) United States $0.631B 0.00
Upstream Bio (UPB) United States $0.622B 0.00
Dianthus Therapeutics (DNTH) United States $0.620B 0.00
Nuvation Bio (NUVB) United States $0.616B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.610B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.602B 0.00
Maze Therapeutics (MAZE) United States $0.593B 0.00
Kura Oncology (KURA) United States $0.577B 0.00
Sana Biotechnology (SANA) United States $0.573B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.572B 0.00
Fortrea Holdings (FTRE) United States $0.567B 15.68
Keros Therapeutics (KROS) United States $0.554B 0.00
Arvinas (ARVN) United States $0.553B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.552B 0.00
Tyra Biosciences (TYRA) United States $0.548B 0.00
Tango Therapeutics (TNGX) United States $0.547B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.544B 0.00
Castle Biosciences (CSTL) United States $0.543B 36.90
MeiraGTx Holdings (MGTX) United States $0.530B 0.00
Cullinan Therapeutics (CGEM) United States $0.528B 0.00
Opthea (OPT) Australia $0.525B 0.00
REGENXBIO (RGNX) United States $0.512B 0.00
Urogen Pharma (URGN) United States $0.511B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.494B 0.00
ATyr Pharma (ATYR) United States $0.483B 0.00
Myriad Genetics (MYGN) United States $0.478B 0.00
Celcuity (CELC) United States $0.476B 0.00
Zenas BioPharma (ZBIO) United States $0.474B 0.00
PureTech Health (PRTC) United States $0.471B 0.00
Septerna (SEPN) United States $0.464B 0.00
Precigen (PGEN) United States $0.449B 0.00
Abivax SA (ABVX) France $0.445B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.442B 0.00
Erasca (ERAS) United States $0.433B 0.00
Cytek Biosciences (CTKB) United States $0.426B 0.00
Tectonic Therapeutic (TECX) United States $0.419B 0.00
Benitec Biopharma (BNTC) United States $0.418B 0.00
Sage Therapeutics (SAGE) United States $0.413B 0.00
Rapport Therapeutics (RAPP) United States $0.407B 0.00
Kamada (KMDA) Israel $0.399B 23.93
Eton Pharmaceuticals (ETON) United States $0.389B 0.00
ITeos Therapeutics (ITOS) United States $0.382B 0.00
Northwest Biotherapeutics (NWBO) United States $0.378B 0.00
Rezolute (RZLT) United States $0.376B 0.00
Humacyte (HUMA) United States $0.374B 0.00
Checkpoint Therapeutics (CKPT) United States $0.371B 0.00
Vigil Neuroscience (VIGL) United States $0.367B 0.00
Fulcrum Therapeutics (FULC) United States $0.366B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.364B 0.00
Absci (ABSI) United States $0.362B 0.00
MBX Biosciences (MBX) United States $0.358B 0.00
Emergent Biosolutions (EBS) United States $0.358B 0.00
Solid Biosciences (SLDB) United States $0.355B 0.00
Ocugen (OCGN) United States $0.350B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.344B 0.00
Terns Pharmaceuticals (TERN) United States $0.343B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.343B 0.00
Aura Biosciences (AURA) United States $0.335B 0.00
Compass Therapeutics (CMPX) United States $0.333B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.328B 0.00
Inventiva S.A (IVA) France $0.325B 0.00
Verastem (VSTM) United States $0.323B 0.00
Abeona Therapeutics (ABEO) United States $0.319B 0.00
Astria Therapeutics (ATXS) United States $0.316B 0.00
Alpha Teknova (TKNO) United States $0.310B 0.00
Allogene Therapeutics (ALLO) United States $0.306B 0.00
Cidara Therapeutics (CDTX) United States $0.304B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.303B 61.50
Entrada Therapeutics (TRDA) United States $0.298B 9.69
Annexon (ANNX) United States $0.297B 0.00
XOMA Royalty (XOMA) United States $0.294B 0.00
Palvella Therapeutics (PVLA) United States $0.292B 0.00
Neurogene (NGNE) United States $0.291B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.289B 0.00
Gossamer Bio (GOSS) United States $0.289B 0.00
Olema Pharmaceuticals (OLMA) United States $0.278B 0.00
Amarin (AMRN) Ireland $0.277B 0.00
Atea Pharmaceuticals (AVIR) United States $0.275B 0.00
Prothena (PRTA) Ireland $0.273B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.273B 0.00
Candel Therapeutics (CADL) United States $0.269B 0.00
2seventy Bio (TSVT) United States $0.266B 0.00
Cartesian Therapeutics (RNAC) United States $0.266B 0.00
DBV Technologies S.A (DBVT) France $0.265B 0.00
Sagimet Biosciences (SGMT) United States $0.264B 0.00
Inozyme Pharma (INZY) United States $0.257B 0.00
Foghorn Therapeutics (FHTX) United States $0.253B 0.00
Lifecore Biomedical (LFCR) United States $0.253B 0.00
Prima BioMed (IMMP) Australia $0.253B 0.00
Cardiff Oncology (CRDF) United States $0.252B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.252B 0.00
Instil Bio (TIL) United States $0.246B 0.00
Tvardi Therapeutics (TVRD) United States $0.244B 0.00
Third Harmonic Bio (THRD) United States $0.244B 0.00
MaxCyte (MXCT) United States $0.242B 0.00
CytomX Therapeutics (CTMX) United States $0.241B 6.23
Aardvark Therapeutics (AARD) United States $0.240B 0.00
Semper Paratus Acquisition (TVGN) United States $0.234B 0.00
BioStem Technologies (BSEM) $0.232B 9.46
Adherex Technologies (FENC) United States $0.230B 0.00
ACELYRIN, INC (SLRN) United States $0.229B 0.00
Design Therapeutics (DSGN) United States $0.222B 0.00
Adocia (ADOCY) France $0.213B 0.00
ScPharmaceuticals (SCPH) United States $0.211B 0.00
I-Mab (IMAB) United States $0.211B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.210B 0.00
AC Immune (ACIU) Switzerland $0.208B 0.00
Inhibrx Biosciences (INBX) United States $0.207B 0.12
Monopar Therapeutics (MNPR) United States $0.207B 0.00
CARGO Therapeutics (CRGX) United States $0.207B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.204B 0.00
GENFIT S.A (GNFT) France $0.201B 0.00
Bright Minds Biosciences (DRUG) United States $0.200B 0.00
Voyager Therapeutics (VYGR) United States $0.199B 0.00
Kodiak Sciences (KOD) United States $0.194B 0.00
Prime Medicine (PRME) United States $0.192B 0.00
Codexis (CDXS) United States $0.186B 0.00
Nuvectis Pharma (NVCT) United States $0.184B 0.00
Editas Medicine (EDIT) United States $0.182B 0.00
Innate Pharma S.A (IPHA) France $0.182B 0.00
INmune Bio (INMB) United States $0.182B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.180B 0.00
Ventyx Biosciences (VTYX) United States $0.177B 0.00
Puma Biotechnology (PBYI) United States $0.177B 4.62
Actuate Therapeutics (ACTU) United States $0.169B 0.00
DiaMedica Therapeutics (DMAC) United States $0.167B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.166B 0.00
EnGene Holdings (ENGN) Canada $0.166B 0.00
Galena Biopharma (SLS) United States $0.165B 0.00
Alector (ALEC) United States $0.162B 0.00
Anika Therapeutics (ANIK) United States $0.162B 0.00
Spero Therapeutics (SPRO) United States $0.162B 0.00
BioAge Labs (BIOA) United States $0.161B 0.00
Fate Therapeutics (FATE) United States $0.160B 0.00
Molecular Partners AG (MOLN) Switzerland $0.157B 0.00
Alpha Cognition (ACOG) Canada $0.154B 0.00
Alumis (ALMS) United States $0.150B 0.00
Kyverna Therapeutics (KYTX) United States $0.150B 0.00
Compugen (CGEN) Israel $0.148B 0.00
Neumora Therapeutics (NMRA) United States $0.145B 0.00
Rapt Therapeutics (RAPT) United States $0.144B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.140B 0.00
Black Diamond Therapeutics (BDTX) United States $0.138B 40.50
23andMe Holding (MEHCQ) United States $0.138B 0.00
Nkarta (NKTX) United States $0.136B 0.00
Agenus (AGEN) United States $0.132B 0.00
Elicio Therapeutics (ELTX) United States $0.128B 0.00
Greenwich LifeSciences (GLSI) United States $0.127B 0.00
BioHarvest Sciences (BHST) Canada $0.126B 0.00
Seer (SEER) United States $0.125B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.121B 0.00
Contineum Therapeutics (CTNM) United States $0.120B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.119B 0.00
Sangamo Therapeutics (SGMO) United States $0.117B 0.00
Theratechnologies (THTX) Canada $0.116B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.116B 0.00
C4 Therapeutics (CCCC) United States $0.115B 0.00
TuHURA Biosciences (HURA) United States $0.114B 0.00
BeyondSpring (BYSI) United States $0.114B 0.00
EXoZymes (EXOZ) United States $0.110B 0.00
Caribou Biosciences (CRBU) United States $0.108B 0.00
Citius Oncology (CTOR) United States $0.105B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.105B 0.00
Invivyd (IVVD) United States $0.102B 0.00
Genelux (GNLX) United States $0.100B 0.00
IO Biotech (IOBT) Denmark $0.099B 0.00
Biomea Fusion (BMEA) United States $0.098B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.098B 0.00
Tenaya Therapeutics (TNYA) United States $0.098B 0.00
HilleVax (HLVX) United States $0.096B 0.00
Whitehawk Therapeutics (WHWK) United States $0.096B 0.00
Entera Bio (ENTX) Israel $0.095B 0.00
Adagene (ADAG) China $0.092B 0.00
Coherus Oncology (CHRS) United States $0.092B 0.00
Cabaletta Bio (CABA) United States $0.091B 0.00
TScan Therapeutics (TCRX) United States $0.091B 0.00
Pliant Therapeutics (PLRX) United States $0.090B 0.00
Nautilus Biotechnology (NAUT) United States $0.090B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.090B 0.00
Coya Therapeutics (COYA) United States $0.090B 0.00
Climb Bio (CLYM) United States $0.087B 0.00
OKYO Pharma (OKYO) $0.086B 0.00
XBiotech (XBIT) United States $0.084B 0.00
Jasper Therapeutics (JSPR) United States $0.084B 0.00
Zura Bio (ZURA) United States $0.083B 0.00
Forte Biosciences (FBRX) United States $0.083B 0.00
PDS Biotechnology (PDSB) United States $0.082B 0.00
Immunic (IMUX) United States $0.081B 0.00
Elutia (ELUT) United States $0.078B 0.00
Inovio Pharmaceuticals (INO) United States $0.076B 0.00
Cellectis S.A (CLLS) France $0.076B 0.00
Senti Biosciences (SNTI) United States $0.075B 0.00
TELA Bio (TELA) United States $0.073B 0.00
IGM Biosciences (IGMS) United States $0.072B 0.00
Genenta Science S.p.A (GNTA) Italy $0.071B 0.00
Immuneering (IMRX) United States $0.071B 0.00
Seres Therapeutics (MCRB) United States $0.070B 0.00
Immix Biopharma (IMMX) United States $0.069B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.069B 0.00
Sutro Biopharma (STRO) United States $0.069B 0.00
MediciNova (MNOV) United States $0.068B 0.00
Skye Bioscience (SKYE) United States $0.067B 0.00
VistaGen Therapeutics (VTGN) United States $0.067B 0.00
Alto Neuroscience (ANRO) United States $0.066B 0.00
CervoMed (CRVO) United States $0.066B 0.00
Ikena Oncology (IKNA) United States $0.066B 0.00
Renovaro (RENB) United States $0.065B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.065B 0.00
Adicet Bio (ACET) United States $0.065B 0.00
Akoya Biosciences (AKYA) United States $0.063B 0.00
Clearside Biomedical (CLSD) United States $0.063B 0.00
Repare Therapeutics (RPTX) Canada $0.062B 0.00
Oncobiologics (OTLK) United States $0.062B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.061B 0.00
Opus Genetics (IRD) United States $0.059B 0.00
Adlai Nortye (ANL) Cayman Islands $0.059B 0.00
Fortress Biotech (FBIO) United States $0.058B 0.00
Werewolf Therapeutics (HOWL) United States $0.058B 0.00
Annovis Bio (ANVS) United States $0.057B 0.00
Exicure (XCUR) United States $0.057B 0.00
Precision BioSciences (DTIL) United States $0.056B 0.00
Quince Therapeutics (QNCX) United States $0.055B 0.00
Adverum Biotechnologies (ADVM) United States $0.054B 0.00
Kronos Bio (KRON) United States $0.054B 0.00
InflaRx (IFRX) Germany $0.054B 0.00
ZIVO Bioscience (ZIVO) United States $0.053B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.052B 0.00
Atara Biotherapeutics (ATRA) United States $0.052B 0.00
Applied Therapeutics (APLT) United States $0.052B 0.00
Kalaris Therapeutics (KLRS) United States $0.052B 0.00
Quantum Biopharma (QNTM) Canada $0.051B 0.00
Shattuck Labs (STTK) United States $0.051B 0.00
VTv Therapeutics (VTVT) United States $0.051B 0.00
Oncolytics Biotech (ONCY) Canada $0.050B 0.00
Artiva Biotherapeutics (ARTV) United States $0.050B 0.00
RenovoRx (RNXT) United States $0.050B 0.00
Aligos Therapeutics (ALGS) United States $0.049B 0.00
Bluebird Bio (BLUE) United States $0.049B 0.00
PepGen (PEPG) United States $0.048B 0.00
Cue Biopharma (CUE) United States $0.048B 0.00
Connect Biopharma Holdings (CNTB) United States $0.047B 0.00
Mersana Therapeutics (MRSN) United States $0.045B 0.00
Rein Therapeutics (RNTX) United States $0.044B 0.00
Celularity (CELU) United States $0.042B 0.00
Alterity Therapeutics - (ATHE) Australia $0.041B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.040B 0.00
Radiopharm Theranostics - (RADX) Australia $0.040B 0.00
OnKure Therapeutics (OKUR) United States $0.039B 0.00
Medicus Pharma (MDCX) United States $0.038B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.038B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.037B 0.00
Clene (CLNN) United States $0.037B 0.00
Estrella Immunopharma (ESLA) United States $0.037B 0.00
Scilex Holding (SCLX) United States $0.036B 0.00
Xilio Therapeutics (XLO) United States $0.035B 0.00
Kezar Life Sciences (KZR) United States $0.035B 0.00
Lantern Pharma (LTRN) United States $0.035B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.034B 0.00
AN2 Therapeutics (ANTX) United States $0.034B 0.00
Pluri (PLUR) Israel $0.034B 0.00
FibroBiologics (FBLG) United States $0.033B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.033B 0.00
Rani Therapeutics Holdings (RANI) United States $0.032B 0.00
CAMP4 Therapeutics (CAMP) United States $0.032B 0.00
ABVC BioPharma (ABVC) United States $0.031B 0.00
MiNK Therapeutics (INKT) United States $0.030B 0.00
Allakos (ALLK) United States $0.030B 0.00
Grace Therapeutics (GRCE) Canada $0.030B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.030B 0.00
Cadrenal Therapeutics (CVKD) United States $0.029B 0.00
Curis (CRIS) United States $0.029B 0.00
ALX Oncology Holdings (ALXO) United States $0.029B 0.00
KALA BIO (KALA) United States $0.029B 0.00
Imunon (IMNN) United States $0.028B 0.00
Dyadic (DYAI) United States $0.028B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
Passage Bio (PASG) United States $0.027B 0.00
Vor Biopharma (VOR) $0.026B 0.00
Generation Bio (GBIO) United States $0.026B 0.00
BioAtla (BCAB) United States $0.025B 0.00
CalciMedica (CALC) United States $0.024B 0.00
Boundless Bio (BOLD) United States $0.024B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
Femasys (FEMY) United States $0.024B 0.00
Chemomab Therapeutics (CMMB) Israel $0.023B 0.00
Elevation Oncology (ELEV) United States $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Gelteq (GELS) Australia $0.022B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.021B 0.00
Q32 Bio (QTTB) United States $0.021B 0.00
Advanced Biomed (ADVB) United States $0.021B 0.00
Ovid Therapeutics (OVID) United States $0.021B 0.00
Longeveron (LGVN) United States $0.020B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.019B 0.00
Cognition Therapeutics (CGTX) United States $0.019B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.019B 0.00
Hoth Therapeutics (HOTH) United States $0.019B 0.00
Cingulate (CING) United States $0.019B 0.00
NextCure (NXTC) United States $0.018B 0.00
Lexaria Bioscience (LEXX) Canada $0.018B 0.00
X4 Pharmaceuticals (XFOR) United States $0.018B 0.00
Leap Therapeutics (LPTX) United States $0.018B 0.00
GeoVax Labs (GOVX) United States $0.017B 0.00
HOOKIPA Pharma (HOOK) United States $0.017B 0.00
IBio (IBIO) United States $0.017B 0.00
SAB Biotherapeutics (SABS) United States $0.017B 0.00
Promis Neurosciences (PMN) Canada $0.017B 0.00
Beyond Air (XAIR) United States $0.016B 0.00
Biorestorative Therapies (BRTX) United States $0.015B 0.00
UNITY Biotechnology (UBX) United States $0.015B 0.00
MetaVia (MTVA) United States $0.015B 0.00
Synlogic (SYBX) United States $0.014B 0.00
Abpro Holdings (ABP) United States $0.014B 0.00
Equillium (EQ) United States $0.014B 0.00
Rallybio (RLYB) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.013B 0.00
BRIACELL THERAP (BCTX) Canada $0.013B 0.00
Allarity Therapeutics (ALLR) United States $0.013B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.012B 0.00
Athira Pharma (ATHA) United States $0.012B 0.00
Aytu BioPharma (AYTU) United States $0.012B 0.00
Bolt Biotherapeutics (BOLT) United States $0.012B 0.00
BioCardia (BCDA) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
BioXcel Therapeutics (BTAI) United States $0.011B 0.00
Aprea Therapeutics (APRE) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.010B 0.00
Novogen (KZIA) Australia $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.009B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.009B 0.00
LakeShore Biopharma (LSB) China $0.009B 0.00
GENPREX (GNPX) United States $0.009B 0.00
BioAffinity Technologies (BIAF) United States $0.009B 0.00
Sensei Biotherapeutics (SNSE) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Evogene (EVGN) Israel $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.008B 0.00
HCW Biologics (HCWB) United States $0.008B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.008B 0.00
Eyenovia (EYEN) United States $0.008B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.008B 0.00
Apollomics (APLM) United States $0.008B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Synaptogenix (SNPX) United States $0.007B 0.00
Arcadia Biosciences (RKDA) United States $0.007B 0.00
Portage Biotech (PRTG) $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Intensity Therapeutics (INTS) United States $0.006B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
Avalon GloboCare (ALBT) United States $0.006B 0.00
180 Life Sciences (ATNF) United States $0.006B 0.00
Polyrizon (PLRZ) Israel $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Mustang Bio (MBIO) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Adial Pharmaceuticals (ADIL) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Affimed (AFMD) Germany $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
Capstone Holding� (CAPS) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00